After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CPRX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Catalyst Pharmaceuticals Inc is $2.56B. A total of 1.39 million shares were traded on the day, compared to an average of 1.19M shares.
In the most recent transaction, Sundaram Preethi sold 2,324 shares of CPRX for 26.41 per share on Jun 10 ’25. After the transaction, the Chief Strategy Officer now owns 42,681 company shares. In a previous transaction on Jun 11 ’25, Sundaram Preethi sold 1,600 shares at 26.42 per share. CPRX shares that Chief Strategy Officer owns now total 41,081.
Among the insiders who bought shares, Sundaram Preethi acquired of 1,600 shares on Jun 11 ’25 at a per-share price of $26.42. In another insider transaction, MCENANY PATRICK J sold 171,748 shares at $26.11 per share on Jun 09 ’25. Company shares held by the Chairman of Board of Directors now total 4,281,702.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CPRX has a high of $26.58 and a low of $15.34.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CPRX’s latest balance sheet shows that the firm has $191.27M in Cash & Short Term Investments as of fiscal 2021. There were $4.20M in debt and $27.06M in liabilities at the time. Its Book Value Per Share was $6.51, while its Total Shareholder’s Equity was $206.83M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CPRX is Buy with a score of 5.00.
